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Abstract In familial Alzheimer's disease (FAD), mutations to I, 
F, and G have been discovered at V642 in the neuron-specific 
version of the amyloid precursor protein APP69g. It has been 
found that expression of each FAD mutant suppresses the 
transcriptional activity of the cAMP response element CRE in a 
Goto-dependent manner in a COS cell clone NK1 [Ikezu et al. 
(1996) EMBO J. 15, 2468-2475]. Here we show that adenylyl 
cyclase (AC) inhibition is probably not the prerequisite for this 
pathway. First, expression of each FAD mutant in NK1 cells had 
no effect on AC activity stimulated by cholera toxin and by 
mutationally activated Gas, although the same expression 
completely repressed the stimulated CRE. Second, a transfected 
activating mutant of Goto inhibited CRE without detectable 
suppression of AC, whereas similarly transfected activating GOj2 
inhibited both AC and CRE. Third, FAD mutant-induced 
inhibition occurred for CRE activity stimulated by dibutyryl 
cAMP. These data suggest that CRE suppression by FAD 
mutants of APP could occur independently of AC. 
© 1997 Federation of European Biochemical Societies. 
1. Introduction 
AD (Alzheimer's disease), the most prevalent neurodegener-
ative disease, is characterized by the presence of extracellular 
senile plaques, whose major constituent is Ap amyloid derived 
from APP (amyloid precursor protein). Among various splicing 
variants transcribed from a single gene, APP695, consisting of 
695 residues, is preferentially expressed in neuronal tissues. In 
patients with FAD (familial Alzheimer's disease), the three mis-
sense mutations V642I, V642F, and V642G have been identified 
in the transmembrane domain of APP6g5 [1]. These mutations 
co-segregate with the AD phenotype [2]. Games et al. [3] have 
reported that overexpression of V642F APP partially mimics 
the neuropathology of AD in transgenic mice. Therefore, struc-
tural alteration of APP is at least one established cause of AD. 
However, little has been known about how these mutations 
cause AD and what abnormality they induce in APP. 
In its architecture, orientation, and localization, APP is 
similar to cell-surface receptors. APP has been implicated in 
cell-surface functions such as adhesion, neurite outgrowth, 
synaptic contact, and locomotion (reviewed in [4]). The cyto-
plasmic domain of APP binds Fe65 protein, which has a 
phosphotyrosine binding domain related to an oncogenic sig-
nal transducer She [5]. It also binds APP-BP1, a gene product 
similar to AXR1 in Arabidopsis; AXR1 is required for normal 
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response to the plant growth hormone auxin [6]. These obser-
vations suggest that APP has not only the structure but also 
the function of a cell-surface receptor. Our own earlier study 
[7] found APP695 has an intrinsic G0-stimulating domain at 
H657-K676 and forms a complex with G0 via H657-K676, 
suggesting that APP695 is a transmembrane G0 activator and 
a potential G0-coupled receptor. It has been confirmed that 
the synthetic H657-K676 peptide activates GQ in vivo [8]. Co-
localization of APP with G0 in growth cones and presynapses 
of neurons [9,10] is in good agreement with the notion that 
APP co-operates with GQ. In further support, APP and G0 
have been implicated in similar or same functions of neurons 
(reviewed in [4]). Ferreira et al. [11] and Culvenor et al. [12] 
independently showed the cellular presence of APP in surface 
and clathrin-coated vesicles, lending additional credence to 
the notion that APP may be a functional signaling receptor. 
Recently, we have demonstrated that cross-linking of APP6g5 
by anti-APP antibody activates GD in reconstituted vesicles 
[13] and activates G-protein downstream Ser/Thr kinases in 
intact cells [14]. Therefore, APP695 can behave as a normal 
G0-coupled receptor, although the physiological significance 
of this function remains unknown. 
What happens to this signal of APP in AD? To address this 
question, we focused on FAD, which is homogenous in cause. 
We have shown that mutant APPs with each of the three FAD 
mutations V642I, V642F, and V642G, collectively referred to 
as FAD-APP here, are constitutively active receptors that can 
activate GD ligand-independently [4,15]. In reconstituted 
vesicles, three recombinant FAD-APPs activated purified G0 
without ligands in a pertussis toxin (PTX)-sensitive manner; 
for this activation, the cytoplasmic domain H657-K676, which 
has been shown to be a selective G0 activator [7,8], was re-
quired. We also reported that expression of the three FAD-
APPs each suppresses transcriptional activity of the cAMP 
response element CRE [15]. This suppression was Ga0 -depend-
ent [15]: in the usual COS cells that express no Ga0 , CRE was 
not suppressed by transfected FAD-APPs; in the NK1 clone 
expressing endogenous Goe0, transfection of FAD-APPs sup-
pressed CRE in a PTX-sensitive manner; in the NK1 cells 
overexpressing human Goc0, similar expression of FAD-APPs 
resulted in greater, almost total suppression of CRE. 
This negative transactivation of CRE by FAD-APP would 
be important because (i) deficient CRE function results in a 
loss of long-term memory in mice [16] and Drosophila [17]; 
and (ii) positive CRE function activates the expression of 
genes required for synaptic plasticity and long-term potentia-
tion of synapses (reviewed in ref. [18]). Therefore, it is con-
ceivable that FAD-APP continuously suppresses the tran-
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scriptional activity of CRE, potentially leading to long-term 
memory loss in patients with F A D . This study was conducted 
to further understand the mechanism whereby FAD-APPs 
suppress C R E through Goc0. There are two possible mecha-
nisms whereby Gcc0 negatively regulates C R E : one is through 
the inhibition of adenylyl cyclase (AC) and the other is AC-
independent. In this study, we investigate the role of AC. The 
results suggest that F A D - A P P could suppress C R E transcrip-
tional activity through an AC-independent target of Gcc0. 
2. Experimental procedures 
All constructs used in this study were as described previously 
[15,19]. NKl cells were grown in DMEM plus 10% fetal calf serum 
and antibiotics. This cell line is a naturally occurring, neuron-like 
transformant of COS-7 cells, which express endogenous Ga0 [20]. 
The measurement of intracellular cAMP accumulation was performed 
as described [21]. A day before transfection, 5 x l 0 4 cells were seeded 
on a 12-well plate. Unless otherwise specified, cDNAs (0.5 ug) were 
transfected with 1 ul LipofectAMINE and incubated for 24 h in a 
serum-free culture. After being washed, cells were labeled with 3 uCi 
of [3H]adenine for another 23 h 30 min. After washing, cells were then 
treated with 2.5 ug/ml CTX (cholera toxin, Calbiochem) and 1 mM 
isobutylmethylxanthine in DMEM at 37°C for 30 min. Reactions 
were terminated by aspiration and the immediate addition of 5% 
ice-cold trichloroacetic acid. Acid-soluble nucleotides were separated 
on two-step ion-exchange columns, and specific accumulation of 
cAMP was expressed as (cAMP/ADP+ATP) X 103. Under similar 
conditions, AC activity was also measured by assaying cAMP con-
tents by radioimmunoassay, in which co-transfection of pactPgal and 
standardization by the transfection efficiency were performed. The 
content of cAMP was expressed as pmol/p-galactosidase IU. These 
two assays for AC activity indicated similar results. For CAT assay, 
105 cells were seeded onto a 6-well plate 24 h before transfection. One 
ug cDNA of interest, 0.2 ug pactPgal, and 0.3 ug CRE-CAT reporter 
were co-transfected with LipofectAMINE (3 ul); this condition al-
lowed expression of FAD-APP comparable to that seen in other ex-
periments without reporter co-transfection. At 24 h after transfection, 
media were changed. CTX (1 ug/ml) was added to these media and 
cells were incubated for another 24 h. CAT assay was performed as 
described [19]. CAT activity was normalized by P-galactosidase activ-
ity. As pactPgal expresses the P-galactosidase activity under the con-
trol of the P-actin promoter, we can detect specific alterations in CRE 
transcriptional activity by this normalization. The CRE is typified by 
the consensus palindromic sequence TGACGTCA and present in the 
promoters of many genes. Our CRE-CAT reporter, described previ-
ously [22], has CRE located in the promoter of the somatostatin gene, 
which is highly responsive to cAMP stimulation [23]. For the dibutyryl 
cAMP (dbcAMP) experiment, cells were treated with 1 mM dbcAMP 
(SIGMA) or 1 ug/ml CTX for the last 12 h, and CRE transcriptional 
activity was measured. Statistical analysis was performed with Stu-
dent's t-test, with p < 0.05 accepted as statistically significant. 
3. Results 
As the major mechanism for C R E suppression is inhibition 
of AC, we initially examined whether expression of F A D -
APPs leads to the suppression of A C activity in N K l cells. 
The left panel of Fig. 1 shows the effects of the three V642 
mutants on c A M P formation. While C T X stimulated c A M P 
accumulation, transfection of wild-type or each F A D mutan t 
of A P P c D N A s resulted in no significant inhibition of this 
elevated c A M P production. Under similar conditions, trans-
fection of F A D - A P P totally suppressed C R E activity (Fig. 1, 
right), as reported previously [15]. Transfection efficiency of 
N K l cells under the conditions we employed was 40-50%, as 
assessed with LacZ expression by transfected pactpgal. As the 
inhibition of CTX-stimulated C R E - C A T by transfected F A D -
A P P was nearly complete, the A C activity should have been 
half inhibited, if C R E suppression was only mediated by A C 
inhibition. Total lack of the effect of FAD-APPs on A C ac-
tivity hence suggests that transfection efficiency may not be 
the major factor in this failure. 
Gas-Q227L, termed gsp [24], is the GTPase-deficient mu-
tant of Gocs that constitutively maintains an active conforma-
tion. To confirm that FAD-APPs were without effect on 
stimulated A C within the same transfected cells, we examined 
whether A C activity promoted by the transfected gsp could be 
antagonized by co-transfected FAD-APP . Transfection of the 
c D N A encoding Ga s -Q227L resulted in significant stimula-
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Fig. 1. Effect of FAD-APP on AC and CRE activities. Left: Effect of FAD-APP cDNA transfection on CTX-stimulated AC activity in NKl 
cells. After either APP695, FAD-APP (V642X APP695, X = F, G, I; WT, wild-type APP695) or empty plasmid was transfected into these cells, 
the cells were treated with or without CTX, and AC activity was measured. Right: Cells were transfected with or without V642F APP cDNA 
under similar conditions as in the left panel, and CAT activity was measured. All values in the figures of this study represent the means ± S.E. 
of three independent experiments with different transfections. 
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type APP had no effect on this promoted cAMP. When either 
FAD mutant of APP cDNA was co-transfected instead of an 
empty plasmid or APP, no gsp-promoted levels of cAMP were 
lowered, indicating that transfection-dependent stimulation of 
AC was not affected by co-transfected FAD-APPs. In these 
experiments, the total amounts of the plasmids were set to be 
constant, and expression of either FAD-APP was not im-
paired by the co-transfection of Gocs-Q227L (data not shown). 
These data suggested no direct action of FAD-APPs on AC in 
situ. We attempted to check whether CRE activity stimulated 
by gsp was inhibited by co-transfected FAD-APP. However, 
we were not able to perform this experiment, as cells did not 
express well FAD-APP when the four plasmids encoding 
FAD-APP, Gocs-Q227L, CRE-CAT, and pact|Jgal cDNAs 
were transfected. 
We pursued different lines of evidence that FAD-APP sup-
presses CRE other than through AC in NK1 cells. In these 
cells, Ga 0 is highly likely to be a signal mediator of FAD-
APPs affecting CRE [15]. Thus, we next examined whether 
Goc0 activation can suppress CTX-stimulated activity of AC 
in NK1 cells. For this purpose, we used Grxo-Q205L cDNA 
which encodes mutationally activated Got0 [19]. As reported 
previously [15], transfection of this mutationally activated 
Gcc0 cDNA resulted in robust suppression of CRE stimulated 
by CTX in NK1 cells (Fig. 3A). We then examined whether 
transfection of Gcxo-Q205L suppresses AC activity. Transfec-
tion of Gcco-Q205L cDNA did not significantly suppress AC 
activity stimulated by CTX (Fig. 3B). In contrast, similarly 
transfected G(Xi2-Q205L, a mutationally activated Goci2, sig-
nificantly suppressed AC and CRE activities both stimulated 
by CTX. As antibodies that equally recognize Goc„ and Go^ 
were not available, we could not compare the expression level 
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Fig. 2. FAD-APP cannot inhibit AC activity stimulated by gsp. 
Cells were transfected with gsp cDNA (0.5 ug) and either FAD-
APP cDNA (0.5 ug; V642X APP69?, X = F, G, I; WT, wild-type 
APPTO). The total amount of DNA in control transfections was ad-
justed to 1 ug using an empty plasmid (mock). cAMP content was 
measured by cAMP radioimmunoassay without CTX by otherwise 
the same protocol. These experiments were repeated at least three 
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Fig. 3. Effect of GTPase-deficient Ga0 on AC and CRE activities. Ef-
fect of GTPase-deficient Ga-Q205L cDNAs on CTX-stimulated AC 
activity in NK1 cells. After either Gao-Q205L, Gai2-Q205L (dose as 
indicated), or empty plasmid (total amount was adjusted at 1 ug) was 
transfected into these cells, the cells were treated with or without 
CTX, and CRE activity (A) and AC activity (B) were measured, as 
described in the legend of Fig. 1. The basal formation of cAMP in A 
was 0.628±0.13. *p<0.05 vs CTX+ in mock transfection. 
of Goc0-Q205L with that of Gai2-Q205L and with their effects 
in these experiments; thus, we could not totally exclude the 
possibility that the transfection efficiency of Gao-Q205L was 
too low to observe the inhibition of AC stimulated in total 
cells by CTX. However, this possibility was unlikely, because 
(i) similarly transfected Gcti2-Q205L resulted in significant 
suppression of AC activity; (ii) transfected Gao-Q205L had 
no effect on AC activity, when it inhibited CRE to a maximal 
degree similar to that by Gai2-Q205L; and (iii) NK1 cells do 
not express type 1 AC (AC1) [21] whose activity Goc0 can 
inhibit specifically [25]. Therefore, the present data suggest 
that Ga0 suppresses CRE other than through AC inhibition, 
whereas Get; suppresses CRE mainly through AC inhibition. 
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Fig. 4. FAD-APP can inhibit CRE activity stimulated by dbcAMP. 
After transfection with FAD-APP (V642X APP695, X = F, G, I) or 
an empty plasmid (mock) under the same condition as in Fig. 1, 
cells were stimulated with or without CTX or dbcAMP for the last 
12 h, and CRE transcriptional activity was measured. 
These results provide evidence that components in the recep-
tor-G protein transduction machinery can transmit inhibitory 
signals to nuclear CRE without modulating cytoplasmic AC. 
If FAD-APPs suppress CRE through an AC-independent 
mechanism, they could also suppress CRE activity stimulated 
by exogenously added cAMP. We thus transfected NKl cells 
with FAD-APP cDNA, and treated the transfected cells with 
1 mM of dbcAMP, a cell-permeable cAMP analog, which 
attains maximal stimulation of CRE in these cells (data not 
shown). With mock transfection, cells increased the transcrip-
tional activity of CRE by several fold in response to this cell-
permeable cAMP. In contrast, cells transfected with each of 
FAD-APPs showed no increase in CRE activity in response to 
this cAMP stimulation (Fig. 4). These data provide clear evi-
dence that the FAD-APP target is the system independent of 
AC in NKl cells. 
4. Discussion 
Our previous study indicated that expression of FAD-APPs 
suppresses transcriptional activity of CRE through Goc0 in the 
present NKl system [15]. As cAMP is the major stimulator of 
CRE [23] and Gcx0 can potentially inhibit AC activity [26], 
inhibition of AC was the most likely mechanism for this sup-
pression. However, neither expression of FAD-APP nor that 
of mutationally activated Goc0, Goc0-Q205L, inhibited AC ac-
tivity, when either of them suppressed CRE activity in the 
same cells. These observations suggest that suppression of 
CRE by transfected FAD-APPs and Gcxo-Q205L may occur 
independently of AC regulation in NKl cells. 
We however emphasize that these transient transfection ex-
periments may be limited. CTX stimulated AC in total cells, 
but we could detect the antagonism of FAD-APP or Ga0-
Q205L for AC, if any, only in transfected cells. Therefore, 
there was a discrepancy in the magnitude of action between 
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CTX-induced stimulation and transfectant-induced inhibition. 
This is not the case with CRE. As the transcriptional activity 
of CRE was detectable only in the cells expressing transfected 
CRE-CAT reporter, the observed CRE change represented 
the change within cells expressing co-transfected FAD-APP 
or Goe0-Q205L (because cells were transfected with the mix-
ture of both DNA). If transfection efficiency was very low, we 
could detect little inhibition of CTX-stimulated AC by trans-
fected FAD-APP, even when FAD-APP did inhibit AC activ-
ity in a single cell; besides, in this case, we could potentially 
detect significant inhibition of CTX-stimulated CRE by trans-
fected FAD-APP. Therefore, one might argue that suppres-
sion of stimulated AC by transfected FAD-APP or Goc0-
Q205L could not be detected due to low transfection effi-
ciency, despite their significant effects on AC in a single cell. 
However, this argument seems unlikely in our case. Given 
the fact that transfection of Gai2-Q205L cDNA resulted in 
significant inhibition of CTX-stimulated AC, it was reason-
able to assume that we were detecting transfection-dependent 
inhibition of AC stimulated by CTX in our system whose 
transfection efficiency was as high as <~40%. In addition, 
the inhibition of CTX-stimulated CRE-CAT by transfected 
FAD-APP or Gao-Q205L was nearly complete. Therefore, if 
the CRE suppression was only mediated by AC inhibition, the 
AC activity should have been unstimulated by CTX in the 
transfected cells (~40%) and completely stimulated by CTX 
in other cells (~60%), resulting in detectable suppression of 
CTX-stimulated AC by transfected FAD-APP or Gao-Q205L 
in total cells. In support, under conditions similar to those we 
employed in the present study, either transfected somatostatin 
type 3 receptor or insulin-like growth factor II receptor max-
imally inhibited AC activity stimulated by CTX to ~ 70% or 
~ 5 0 % levels, respectively [21,27]. The total lack of significant 
effects of FAD-APPs on AC suggests that transfection effi-
ciency may not be the major factor for the negative observa-
tion, allowing for the notion that FAD-APPs repress CRE 
independently of AC regulation in our system. 
One possible method of confirming this notion was to use 
NKl cell lines stably overexpressing FAD-APPs. However, 
despite our repeated trials, we failed to establish such cell 
lines. This is however consistent with the fact that transfected 
FAD-APP causes cell death in NKl cells [20]. We therefore 
tried to obtain alternative confirmation by making use of a 
different AC stimulator which only affects AC in FAD-APP-
expressing cells: mutationally activated Gas cDNA. As is the 
case with the CRE reporter gene, the activated Gets gene 
would be taken up by cells together with FAD-APP genes 
complexed with a lipofection compound in the media. There-
fore, it is highly likely that the Gocs mutant can only affect AC 
within the cells expressing APP or FAD-APPs. The results 
revealed that transfected FAD-APPs had no effect on AC 
stimulation by co-transfected Gas-Q227L. We again empha-
size that in this system, AC was probably stimulated only in 
the cells expressing transfected genes. Therefore, the observed 
failure of AC inhibition by FAD-APP provides strong evi-
dence that FAD-APP has no effect on stimulated AC inside 
the transfected cells. 
Another line of confirmation was in the observation that 
transfected FAD-APPs could also suppress CRE activity 
stimulated by dbcAMP. Since this cell-permeable cAMP ana-
log can act directly on protein kinase A, which stimulates 
CRE, the observed antagonism of CRE by FAD-APP against 
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c A M P indicates that FAD-APPs are able to suppress C R E by 
regulating the downstream targets of AC. Therefore, suppres-
sion of C R E by F A D - A P P should not be the consequence of 
A C inhibition in our system. 
Wha t target and mechanism could underlie the actions of 
F A D - A P P and G a 0 ? At present, inhibition of A C and calci-
um channels are all known targets of Gcc0 [28]. The calcium 
channel inhibitable by G a 0 is a voltage-sensitive type, whose 
distribution is limited to excitable cells, which N K 1 cells are 
not. Given the AC-independent C R E regulation by F A D -
APPs and G a 0 shown here, the CRE-suppressing target of 
F A D - A P P is therefore most likely a novel effector of G O Q . 
It has been established that cAMP-dependent protein kinase 
A and calcium/calmodulin-dependent kinase (CaM kinase) IV 
each stimulates the CRE-binding protein CREB, the major 
regulator of C R E function, by phosphorylating its Ser133 res-
idue [23,29]. In contrast, C a M kinase II activates the function 
of C R E B by phosphorylating its Serl33 residue but sup-
presses it by additionally phosphorylating it on Serl42 [29, 
30]. Therefore, C a M kinase II may be a likely candidate for 
the action mediator of FAD-APPs . Consistent with this pos-
sibility, C a M kinase II has been implicated in essential mem-
ory processes such as long-term hippocampal potentiation of 
synapses [31,32] and spatial learning [33]. It must be examined 
whether C a M kinase II is activated by the transfection of 
F A D - A P P and Goc0-Q205L, and whether inhibition of this 
enzyme precludes C R E from the suppression by FAD-APP . 
Finally, it should be underscored that the results of this 
work do not exclude an intermediary role for A C in F A D -
APP-induced C R E suppression in neurons. Inhibition of AC1 
by Gct0 does result in impaired function of cAMP, leading to 
C R E suppression [23]. However, using ACl- lacking N K 1 
cells, the present study shows, for the first time, that F A D -
APPs and activated G a 0 can suppress C R E without inhibiting 
A C activity. Hence, in neurons, which express AC1 in addi-
tion to other A C subtypes, FAD-APPs potentially suppress 
C R E by both AC-dependent and -independent mechanisms. 
The extent of FAD-APP-induced inhibition of C R E in neu-
rons is therefore expected to be larger than in other types of 
cells. Given the fact that C R E regulates expression of so many 
genes, some of which are common across neurons and non-
neurons, this dual mechanism could potentially underlie the 
higher vulnerability of nervous systems in A D and also allow 
for the extraneuronal occurrence [34] of A D disorders which 
mirror the abnormality in neurons. 
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